Notes / Company

Aarti Drugs Ltd.

AARTIDRUGS BSE 524348 ISIN INE767A01016 Pharmaceuticals

Fundamentals

Market cap: ₹3,402 cr
P/E: 17.45×
ROE: 12.28%
Debt / equity: 0.45
Div yield: 0.54%
52-week range: 318.95 — 564.05

Research on Tijori Finance

Company snapshot

Aarti Drugs Ltd.

Pharmaceuticals

₹3,693 cr

P/E 18.95×

Latest quarter · Mar 2026

Sales₹720 cr

Net profit₹55 cr

Op. margin+13.3%

EPS₹6.05

Strength & growth

Debt / equity0.45×

Current ratio1.60×

Sales CAGR+8.2%

EPS CAGR−2.8%

The timeline — 1 note on Aarti Drugs Ltd.

July 2026

18 Jul 26 · 10:42 PM IST Brief

Brief · Order Wins · Small cap

Aarti Drugs' key amines unit faces GPCB closure order

The Gujarat Pollution Control Board has ordered closure of Aarti's methylamine plant at Saykha within 15 days for water pollution violations, threatening a backward integration project.

Verify on exchange BSE filings for AARTIDRUGS NSE filings for AARTIDRUGS Tijori Finance company page